Season 3 - Ep.27: 'ChatGPT, MD?': large language models at the bedside - Management decisions in myocarditis

5 snips

Nov 20, 2025

Folkert Asselbergs, a cardiologist and expert in digital health and AI, discusses the implications of large language models (LLMs) in clinical settings, including their role in patient engagement and reducing clinician workload. Massimo Imazio, chair of the upcoming ESC guidelines on myocarditis, delves into the nuances of diagnosing myocarditis, emphasizing cardiac MRI and biopsies when necessary. He also provides critical insights on managing immune-related myocarditis and guidelines for returning patients to physical activity.

Ask episode

AI Snips

Chapters

Transcript

Episode notes

INSIGHT

Domain LLMs Deliver Traceable Guideline Answers

Domain-specific LLMs trained on guideline texts can provide traceable, guideline-based answers.
The ESC chat links answers to source PDFs and highlights the exact phrases used for transparency.

INSIGHT

AI Can Match Empathy And Augment Care

Patient evaluations rate AI chatbots as at least as empathic as physicians in studies when assessed by patients.
A hybrid model combining in-person care with 24/7 AI avatars could democratize information for patients and caregivers.

ADVICE

Automate Documentation To Reduce Workload

Use LLMs to reduce clinician workload by automating discharge letters, patient replies, and reporting tasks.
Expect clinical decision support next, but validate rigorously before clinical deployment.

Get the Snipd Podcast app to discover more snips from this episode

Get the app

This episode covers:

Cardiology This Week: A concise summary of recent studies
'ChatGPT, MD?' - Large Language Models at the Bedside
Management decisions in myocarditis
Statistics Made Easy: Mendelian randomisation

Host: Emer Joyce

Guests: Carlos Aguiar, Folkert Asselbergs, Massimo Imazio

Want to watch that episode? Go to: https://esc365.escardio.org/event/2179

Want to watch that extended interview on 'ChatGPT, MD?': Large Language Models at the Bedside? Go to: https://esc365.escardio.org/event/2179?resource=interview

Disclaimer:

ESC TV Today is supported by Bristol Myers Squibb and Novartis through an independent funding.

The programme has not been influenced in any way by its funding partners.

This programme is intended for health care professionals only and is to be used for educational purposes.

The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

The ESC is not liable for any translated content of this video. The English language always prevails.

Declarations of interests:

Stephan Achenbach, Folkert Asselbergs, Yasmina Bououdina, Massimo Imazio, Emer Joyce, and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede.

John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.

Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo.

Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.

Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.

Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.